A T2-weighted MRI-based radiomic signature for disease-free survival in locally advanced cervical cancer following chemoradiation: An international, multicentre study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A T2-weighted MRI-based radiomic signature for disease-free survival in locally advanced cervical cancer following chemoradiation: An international, multicentre study

Published:2024-10 Issue: Volume:199 Page:110463
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Marsilla Joseph,Weiss Jessica^ORCID,Ye Xiang Y.,Welch Mattea,Milosevic Michael^ORCID,Lyng Heidi,Hompland Tord,Bruheim Kjersti,Tadic Tony^ORCID,Haibe-Kains Benjamin,Han Kathy^ORCID

Funder

Princess Margaret Cancer Foundation

Princess Margaret Hospital Foundation

Publisher

Elsevier BV

Reference27 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): A multicentre prospective cohort study;Pötter;Lancet Oncol,2021

3. Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy

4. Radiomics: Images are more than pictures, they are data;Gillies;Radiology,2016

5. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach;Aerts;Nat Commun,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP